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Abstract
Objectives: To demonstrate and evaluate the usefulness of two dimensional and Doppler echocardiography 
in the diagnosis of endomyocardial fibrosis (EMF) in countries with poor resources. Also to evaluate the 
clinical assessment as a predictor of echocardiographically proven EMF.
Design-. Descriptive hospital based study.
Setting: Muhimbili National Hospital, Dar es Salaam, Tanzania.
Subjects: 39 patients (27 male and 12 female, mean age 13.5 years) attending our Cardiac Clinic were 
investigated to determine the extent to which specific features could be diagnosed by transthoracic 
echocardiography.
Main Outcome Measures: Identifying and characterizing echocardiographic features specific for diagnosing 
EMF non-invasively.
Results: Only eight (21%) patients had a correct clinical diagnosis, leaving 79% of the,patients at risk of being 
misdiagnosed and hence wrongly receiving expensive treatment. The majority of the patients (69.2%) 
presented with signs of elevated systemic venous pressure due to right ventricular EMF.
Conclusion: We have demonstrated that echocardiography remains a fundamental investigation in the least 
developed countries in achieving the correct diagnosis.
Introduction
Endomyocardial fibrosis (EMF) is endemic in parts of 
Africa, South and Central America, and Asia, and.occurs 
sporadically throughout the world.1-3 A few cases have 
been reported in Caucasians in temperate climates rarely in 
the absence of prior residence in tropical countries.4 This 
disease, which was first described by Davies et al.5 is 
essentially restrictive ardiomyopathy characterized by EMF 
or thickening, usually involving the apex and outflow 
tracts of one or both ventricles.
The causes of EMF remain unknown. Several aetiologic 
factors jrave been suggested, including parasitic infections 
or hyper reaction to malaria, filariasis and streptococcus, 
viral myocarditis, malnutrition and cation imbalance.1,5’6'7 
In sub-Sahara Africa, where the disease is most prevalent, 
the typical diet is high in a tuber called cassava, which 
contains high concentrations of a rare element cerium 
(Ce). The combination of high cerium levels and 
hypomagnesemia has been shown to produce EMF-like 
lesions in laboratory animals.8 Rarely a familial tendency
Cent AfrJMed 2004;50(9/10):91-4
has been noted in some parts of Africa such as Uganda and 
Zambia.9
The medical treatment of EMF is often difficult and not 
particularly effective in patients with advanced disease. 
The overall prognosis in these patients is poor and depends 
on the degree and location of involvement within the 
heart.10 Typically, the disease has an insidious onset, with 
development of increasing severe right and left-sidcd hcart 
failure. Sudden death or syncopal episodes are not as 
common in EMF as they are in other causes of restrictive 
cardiomyopathy. However, atrial fibrillation does occur 
and is more frequent in patients with right ventricular 
disease.11 Digitalis glycosides may be helpful in controlling 
the ventricular rate in patients with atrial fibrillation but the 
response of congestive symptoms is disappointing. 
Diuretics are not particularly helpful in the treatment of 
ascites. Surgical excision (decorticating) of the fibrotic 
endocardium and replacement of the mitral and/or tricuspid 
valve have lead to substantial sym ptom atic 
improvement.12,13 Operative mortality has been high, 
running between 15,and 25% in the larger series.10,12,13 The
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importance of establishing ante mortem diagnosis of EMF 
is to rule out surgically correctable causes of restrictive 
heart disease, especially'constrictive pericarditis, which is 
common in the tropics due to mycobacterium tuberculosis 
infections. With this background, the purpose of this study 
was to describe our experience with 39 cases of EMF 
diagnosed using the transthoracic echocardiography 
technique and to determine and emphasize the extent to 
which specific features of this disease could be recognized 
by this method.
Materials and Methods
Following the introduction of an echocardiography machine 
at Muhimbili National Hospital in 1991, patients from all 
regions of the country with complex cardiac lesions were 
referred to our hospital for further evaluation and treatment. 
From May 1992 to April 1999,6 336 patients were referred 
to our Cardiac Clinic for further evaluation. Four 
cardiologists evaluated these patients and concluded the 
clinical diagnosis before echocardiography examination. 
The echocardiography examinations were done by two 
cardiologists. Among 6 336 patients, 39 (0.62%) patients 
were found to have EMF echocardiographically. These 
patients, who were of African origin, were studied 
consecutively and prospectively. Their echocardiography 
tapes were reviewed by another cardiologist who didn’t do 
the echocardiography examination. All subjects gave 
written informed consent to participate in this study, and 
the hospital ethical committee approved the study protocol. 
The clinical presentation and routine laboratory data, 
including total and differential white blood cell counts, 
were done in all patients diagnosed as having EMF. 
Electrocardiography and chest X-ray studies were also 
done.
M-mode, two dimensional echocardiography, Doppler 
and colour flow mapping were performed in all patients 
using a Sonos 1000 Hewlet Packard Machine with 2.25 to 
7.0 MHZ transducers. All the standard positions i.e. 
measurements of the cavities and walls of the heart were 
performed as recommended by the American Society of 
Echocardiography.14 Mitral and tricuspid velocities were 
recorded from the apical window with pulse wave Doppler. 
To obtain this, approximately 2 to 3mm sample volume 
was placed between the edges of mitral and tricuspid 
leaflets during diastole phase. We measured the peak 
velocity of early diastolic filling (E wave) and late filling 
atrial contraction (A wave) and deceleration time of the E 
wave of both the mitral and tricuspid valves. Continuous 
wave and colour Doppler echocardiography were used to 
determine the presence and grading of mitral and tricuspid 
regurgitations. We further determined the percentage of 
difference of the peak tricuspid incompetence velocities 
between inspiration and expiration. We calculated right 
systolic pressure from tricuspid incompetence velocity by 
using the Bernoulli formula.14 Pulmonary veins were 
observed from the transthoracic window. All recordings
were done using a Sanyo Video recorder. We used the 
echocardiographic criteria established previously to 
diagnose endomyocardial fibrosis.1A7 Due to unavailability 
of facilities at the hospital, angiography was not performed.
All variables are presented as percentages. The difference 
between the inspiratory and expiratory mitral and tricuspid 
measurements was calculated as a percentage of increase 
relative to inspiration.
Results
From May 1992 to April 1999, EMF was diagnosed in 39 
of 6 336 patients who had echocardiographic examination 
at Muhimbili National Hospital. Among the 39 patients, 27 
were male and 12 female, a M:F ratio of 2:1. The mean age 
of these patients was 13.5 years (range six to 57 years).
Table I shows the initial clinical diagnoses of the 39 
patients with EMF before echocardiography was done. 
Only eight (20.51%) patients had a correct diagnosis of 
EMF. Twelve (30.77%) patients had a diagnosis of dilated 
cardiomyopathy and seven (17.95%) had a diagnosis of 
pericardial effusion due to tuberculosis. Three patients 
who had clinical diagnoses of EMF were later found to 
have constrictive pericarditis using echocardiography.
Table I: Clinical diagonoses of the 39 patients with EMF.
D ia g n o s is N o . o f  P a t ie n ts %  ’
D ila ted  card io m yo p ath y 12 3 0 .7 7
E n d o m y o card ia l fibrosis 8 2 0 .5 1
P ericard ia l e ffus ion 7 1 7 .9 5
M itra l va lv e  d is e a s e 5 1 2 .8 2  ’
C o n stru ctive  p ericard itis 5 1 2 .8 2
E bstein  a n o m a ly 1 2 .5 5
A trial m yxom a 1 2 .5 5
Table II shows the symptoms complained of by the 39
patients with EMF. The most common symptom was 
abdominal swelling followed by facial swelling. Ankle 
swelling prevalence was 35.9%. Ankle swelling was either 
absent or minimal; consequently the legs were thin and 
together with the massive ascites, gave an “egg on stick” 
appearance in 14 patients.
Table !I: Symptoms o f the 39 patients with EMF.
S y m p to m P r e v a le n c e  (% )
A bd o m in al sw elling 7 9 .5
F ac ia l sw elling 7 6 .9
B reath lessn ess 6 6 .7
C ough 6 6 .7
Palp ita tions 4 1 .0
C h es t tightness 3 8 .5
A n kle  sw elling 3 5 .9
Fatigue 3 5 .9
Jau n d ice 23 .1
A bd o m in al pain 1 7 .9
Loss o f w eig h t 1 0 .3
Protruding e y es 1 0 .3 .
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Table III shows the physical signs observed in the 39 
patients with EMF. EMF may affect either or both ventricles. 
The majority of our patients had right ventricular EMF. 
The common cardiac signs were raised angular venous 
pressure, feeble peripheral pulses and muffled heart sounds. 
The common extracardiac signs were ascites, hepatomegoly 
and growth retardation.
Table Ilia: Cardiac signs observed in 39 patients with 
EMF.
S ig n P re v a le n c e  (% )
R a ised  ju g u la r v e n o u s  p ressu re 8 9 .7
F e e b le  p erip h era l pulse 8 4 .7
M u ffled  h ea rt sou nds 6 9 .2
P reco rd ia l h e a v e 5 1 .3
Tricu sp id  reg u rg ita tio n  m u rm u r 5 1 .3
T h ird  h e a r sound 4 1 .0
A tria l fibrillation 2 5 .6
M itra l reg u rg ita io n  m urm ur 15 .4
Table IHb: Extracardiac signs observed in 39 patients with 
EMF.
S ig n P r e v a le n c e  (% )
A sc ites 8 4 .7
H e p a to m e g a ly 8 4 .6
G ro w th  re ta rd atio n 5 8 .9
P e d a l o e d e m a 4 6 .2
B as al crack le s 4 1 .0
S p le n o m e g a ly 2 0 .5
P roptos is 1 5 .4
Ja u n d ice 1 5 .4
C en tra l cyanosis 10 .3
D ig ita l c lubbing 10 .3
Table IV shows the echocardiographic findings in 39 
patients with EMF. Both the four chamber apical, 
parasternal and subcostal views were used to assess the 
atria and the ventricles. Among the 39 patients proven to 
have EMF using echocardiography, 27 (69.23%) patients 
had right-sided EMF, while six (15.38%) patients had 
biventricular EMF. In all cases of right-sided EMF, the 
right atria were enlarged (ranging from 4.7 to 10 cm (mean 
6.5cm). Three (7.69%) patients had right atria thrombi 
with no signs of embolization to the lungs.
Table IV: Echocardiographic findings in 39 patients with 
EMF.
F in d in g N o . o f  P a t ie n ts %
R ight ve n tric u la r E M F 2 7 6 9 .2 3
B iventricu lar E M F 6 1 5 .3 8
Left ve tn ric u la r E M F 4 1 0 .2 6
S e p ta l E M F 2 5 .1 3
P ericard ia l effus ion 14 3 5 .8 9
M o d e ra te  to  s e v e re
T ricusp id  regurg itation
(G ra d e  3  a n d  4 ) 21 5 3 .8 5 .
R ig h t a rtia l th rom bus 3 7 .6 9
Discussion
EMF is not observed in children younger than four years. 
Those most commonly affected are older children (five to 
15 years) and young adults, but a case has been reported in an 
individual aged 70 years.8 In Nigeria, 50% of the patients 
were less than 15 years and 70% were under 20 years.2 The 
age incidence in other African countries is similar. A slight 
female predilection has been observed in Uganda, where 
as in Nigeria and Ivory Coast, EMF affects more males 
than females.2 In our study, the mean age of our patients 
was 13.5 years (range six to 57 years). We found more 
males than females affected, supporting previous findings.
The diagnosis of EMF in Tanzania, has hitherto been 
mainly clinical, until 1991 when echocardiography was 
introduced in our national hospital. Even to date 
echocardiography equipment, technicians or doctors who 
can perform it, are limited to big urban government and 
private hospitals, making clinical diagnosis still an 
important tool. The commonly available means of 
investigation such as the electrocardiogram and chest 
roentgenograms are helpful but not specific, neither 
sensitive, for the diagnosis of EMF. In developed countries 
angiography has been for many years one of the main tools 
for the diagnosis of EMF.13'15 However, echocardiography 
has been shown to be useful and precise in making the 
diagnosis of EMF.8 Thus with echocardiography, it is 
possible non-invasively to differentiate EMF from other 
conditions which clinically mimic EMF, such as constrictive 
pericarditis, dilated cardiomyopathy, mitral valve disease, 
Ebstein anomaly and atrial myxoma.16 Our assumption 
that echocardiography is more beneficial than physical 
examination per se was reinforced by the fact that in this 
study only eight (21%) patients had a correct clinical 
diagnosis, leaving 79% at risk of being misdiagnosed and 
incorrect expensive treatment instituted.
The symptoms and signs of patients with EMF varied 
according to the stage and severity of the disease, as well 
as to the side of the chamber affected. Left-sided 
involvement results in symptoms of pulmonary congestion
i.e. clinical findings often resemble those of mitral valve 
disease, while predominant right-sided disease may show 
markedly elevated systemic venous pressure and tricuspid 
regurgitation. In our study, the majority of the patients 
(69.23%) had right ventricular EMF with marked 
elevation of systemic venous pressure. This observation 
supports the previous studies which had similar 
phenomenon.11,17
Contrary to one post portent18 finding of combined right 
ventricular and left ventricular disease, in 50% of cases, 
pure left ventricular in 40% and pure right ventricular 
disease in the remaining 10% of their patients, we found 
the reverse. In our study, 27 (69.23%) patients had right 
ventricular disease, six (15.38%) patients had biventricular, 
four (10.26%) left ventricular and two (5.13%) patients 
had septal disease. No obvious reason could explain these 
findings. However, these results led us to seriously consider 
the possibility of geographical variation in the chamber(s) 
affected by EMF. Further studies to clarify this are 
underway.
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The common findings on right ventricular EMF were, 
aneurismal right atrium, dilatation of the right ventricular 
outflow tract, dense fibrous tissue obliterating the apex of 
the right ventricle and paradoxical interventricular septal 
motion. In left ventricular EMF, the left atrium dilated with 
plastered down posterior mitral valve leaflet, patchy 
enhancement of the endocardial echo and obliteration of 
jthe left ventricle apex with evidence of endocardial 
calcification. Right atrial thrombi occurs commonly in 
EMF3,18 and major systemic or pulmonary embolism is 
uncommon.19 In our study three (7.69%) patients had right 
atria thrombus and none had signs of embolication to the 
lungs.
In considering the significance of our findings, several 
vital limitations must be kept in mind. While our study 
adds to the body of evidence of the general presentation of 
EMF in Africa, we are aware that echocardiography is not 
the most accurate diagnostic tool for endomyocardial 
fibrosis in this era of cut edge science. However, in our 
least developed countries, it provides the opportunity for a 
better diagnosis and give us the general picture of EMF. 
Recently it has been shown that transoesophageal 
echocardiography is more informative in EMF patients 
with an unsuitable acoustic window. It is more accurate 
than the transthoracic approach in the study of pulmonary 
veins and severity of mitral regurgitation. This was not 
done due to lack of these facilities. Lastly, due to inadequate 
documentation and various economic reasons the majority 
of patients could not turn up on appointment dates for 
follow up. This made the follow up data difficult to analyse 
properly and hence the drawing of correct conclusions. 
Putting all together, the ministries involved should allocate 
more funds to purchase diagnostic equipment, train more 
staff and organize a multicentre, multidisciplinary, well 
structured approach to diagnose and care for EMFpatients. 
This is essential if we need to combat this debilitating 
condition in our African continent.
Conclusion
EMF occurs in T anzania, as in many other tropical countries 
and the disease affects children and young adults. It is 
anticipated that echocardiography will continue to play an 
important role in the identification of EMF, at least in the 
developing countries, for years to come. As shown, patients 
having this pathology share common characteristic 
diagnostic sighs and echocardiography pattern.
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